Target- |
MechanismImmunologic cytotoxicity [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismHSPH1 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismImmunostimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with M Group Holdings Ltd.
0 Patents (Medical) associated with M Group Holdings Ltd.
100 Deals associated with M Group Holdings Ltd.
100 Translational Medicine associated with M Group Holdings Ltd.